In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
In vitro activity of LB10522 was compared with those of cefpirome, ceftazidime, ceftriaxone, and cefoperazone against clinical isolates. Against gram-positive bacteria, LB10522 was most active among the compounds tested. It was fourfold more active than cefpirome against methicillin-susceptible Stap...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
1996
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163424/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8843288/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.8.1825 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|